Mannequin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.00 M
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.96 Cr
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth 23.24%
- Profit Growth 247.48%
- Ebitda 95.48%
- Net Worth 48.93%
- Total Assets -8.17%
About Mannequin Pharmaceuticals
Mannequin Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 December 2014 and has a history of Ten years and one month. Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹6.96 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Debendra Dash and Bidhu Patra serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233OR2014PTC018518
-
Company No.
018518
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Dec 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Mannequin Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bidhu Patra
|
Managing Director | 16-Dec-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Debendra Dash
|
Director | 16-Dec-2014 | Current |
Financial Performance of Mannequin Pharmaceuticals.
Mannequin Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.24% increase. The company also saw a substantial improvement in profitability, with a 247.48% increase in profit. The company's net worth Soared by an impressive increase of 48.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mannequin Pharmaceuticals?
Unlock access to Mannequin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Rnd Laboratories Private LimitedDebendra Dash is a mutual person
-
Umatri Pharma & Packaging Private LimitedBidhu Patra is a mutual person
Charges (Loans)
₹6.96 Cr
₹1.50 Cr
Charges Breakdown by Lending Institutions
- Others : 6.65 Cr
- Sidbi : 0.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2023 | Sidbi | ₹3.10 M | Open |
| 26 Nov 2021 | Others | ₹3.75 Cr | Open |
| 28 Sep 2018 | Others | ₹2.90 Cr | Open |
| 31 Jul 2015 | Others | ₹1.50 Cr | Satisfied |
How Many Employees Work at Mannequin Pharmaceuticals?
Mannequin Pharmaceuticals has a workforce of 34 employees as of Sep 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mannequin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mannequin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.